| Issue Date | Title | Author(s) |
| 2020-05-01 | Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer. | Butow, P; Davies, G; Napier, CE; Schlub, T; Best, MC; Bartley, N; Juraskova, I; Meiser, B; Ballinger, ML; Biesecker, B; Goldstein, D; Thomas, DM; PiGeOn Project, |
| 2019-07-31 | Patient perspectives on molecular tumor profiling: "why wouldn't you?" | Best, MC; Bartley, N; Jacobs, C; Juraskova, I; Goldstein, D; Newson, AJ; Savard, J; Meiser, B; Ballinger, M; Napier, C; Thomas, D; Biesecker, B; Butow, P; Tucker, K; Schlub, T; Vines, R; Vines, K; Kirk, J; Young, MA |
| 2022-08 | Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting. | Best, MC; Butow, P; Savard, J; Jacobs, C; Bartley, N; Davies, G; Napier, CE; Ballinger, ML; Thomas, DM; Biesecker, B; Tucker, KM; Juraskova, I; Meiser, B; Schlub, T; Newson, AJ |
| 2022-07 | Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients. | Butow, PN; Best, MC; Davies, G; Schlub, T; Napier, CE; Bartley, N; Ballinger, ML; Juraskova, I; Meiser, B; Goldstein, D; Biesecker, B; Thomas, DM; members of the PiGeOn Project, |
| 2022-07 | Validation of the multidimensional impact of Cancer Risk Assessment Questionnaire to assess impact of waiting for genome sequencing results. | Best, M; Napier, C; Schlub, T; Bartley, N; Biesecker, B; Ballinger, M; Butow, P |
| 2022-02 | Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study. | Butow, P; Davies, G; Napier, CE; Bartley, N; Ballinger, ML; Biesecker, B; Juraskova, I; Meiser, B; Schlub, T; Thomas, DM; Goldstein, D; Best, MC; Members of the PiGeOn Project, |
